Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Cancer Immunology, Immunotherapy : CII|January 1, 1989
In vitro modulation of natural killer cell activity in non-Hodgkin's lymphoma patients after therapyB A Mehta, M N Satam, S H Advani, et al.Human Immunology|June 20, 1998
Studies on functional status of circulating lymphocytes in unaffected members from cancer familiesL A Shevde, N N Joshi, S R Shinde, et al.Neoplasma|January 1, 1994
Tumor cytotoxicity and production of interleukin-1 and tumor necrosis factor from blood monocytes of cervical carcinoma patientsJ J Nadkarni, A K De, K J Jhaver, et al.Neoplasma|January 1, 1991
Lymphokine activated killer cells and interleukin-2 production in patients with cervical carcinomaA K De, K G Jhaver, M R Kamat, et al.Cancer Immunology, Immunotherapy : CII|October 13, 1998
CD40-ligation-mediated protection from apoptosis of a Fas-sensitive Hodgkin's-disease-derived cell lineS S Metkar, K N Naresh, A A Redkar, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1986
Isolation and dissociation of immune complexes from pleural effusions of lymphoma patientsG V Patel, M N Satam, G R Nadkarni, et al.Neoplasma|January 1, 1981
Immune status in untreated cervical cancer patientsM N Satam, J J Nadkarni, J S Nadkarni, et al.Hybridoma|April 1, 1988
Unique monoclonal antibodies against soluble membrane proteins of human CML myelocytes reactive with human myeloid progenitor cellsJ S Nadkarni, L S Nadkarni, S H Advani, et al.Experimental Cell Research|February 10, 2000
Ceramide-induced apoptosis in fas-resistant Hodgkin's disease cell lines is caspase independentS S Metkar, M Anand, P P Manna, et al.Journal of Cancer Research and Clinical Oncology|June 8, 1999
Immune functions, clinical parameters and hormone receptor status in breast cancer patientsL A Shevde, N N Joshi, S B Dudhat, et al.Pageof 4